Compare Katakura Industries Co., Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 91,946 Million (Small Cap)
18.00
NA
0.02%
-0.24
5.96%
0.94
Revenue and Profits:
Net Sales:
10,507 Million
(Quarterly Results - Dec 2025)
Net Profit:
901 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22402.16%
0%
22402.16%
6 Months
22402.16%
0%
22402.16%
1 Year
22402.16%
0%
22402.16%
2 Years
23105.36%
0%
23105.36%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Katakura Industries Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.51%
EBIT Growth (5y)
9.49%
EBIT to Interest (avg)
29.19
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.43
Tax Ratio
49.16%
Dividend Payout Ratio
33.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.23%
ROE (avg)
5.85%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.06
EV to EBIT
14.13
EV to EBITDA
9.34
EV to Capital Employed
1.08
EV to Sales
1.97
PEG Ratio
0.41
Dividend Yield
0.02%
ROCE (Latest)
7.67%
ROE (Latest)
5.96%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
10,507.00
9,390.00
11.90%
Operating Profit (PBDIT) excl Other Income
1,923.00
2,312.00
-16.83%
Interest
32.00
33.00
-3.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
901.00
1,339.00
-32.71%
Operating Profit Margin (Excl OI)
100.00%
175.50%
-7.55%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 11.90% vs -1.16% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -32.71% vs -39.79% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
40,652.00
39,424.00
3.11%
Operating Profit (PBDIT) excl Other Income
8,757.00
6,947.00
26.05%
Interest
131.00
141.00
-7.09%
Exceptional Items
0.00
-902.00
100.00%
Consolidate Net Profit
5,815.00
3,744.00
55.32%
Operating Profit Margin (Excl OI)
144.10%
104.60%
3.95%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.11% vs -1.37% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 55.32% vs 15.88% in Dec 2024
About Katakura Industries Co., Ltd. 
Katakura Industries Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






